GRGDSPK is an inhibitory peptide for RGD-mediated adhesion between integrin and extracellular matrix molecules.
CAT No: R1401
CAS No:111119-28-9
Synonyms/Alias:Grgdspk;111119-28-9;Gly-arg-gly-asp-ser-pro-lys;Glycyl-arginyl-glycyl-aspartyl-seryl-prolyl-lysine;CHEMBL58763;(2S)-6-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]hexanoic acid;DTXSID20149506;EMD 56574;N2-(1-(N-(N-(N-(N2-Glycyl-L-arginyl)glycyl)-L-alpha-aspartyl)-L-seryl)-L-prolyl)-L-lysine;L-Lysine, N2-(1-(N-(N-(N-(N2-glycyl-L-arginyl)glycyl)-L-alpha-aspartyl)-L-seryl)-L-prolyl)-;MFCD00076462;H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH;SCHEMBL891576;DTXCID7071997;ZRVZOBGMZWVJOS-VMXHOPILSA-N;HY-P0322;BDBM50079446;NCGC00167196-01;DA-74135;FG109749;MS-31214;G12230;Gly-Arg-Gly-Asp-Ser-Pro-Lys, >=97% (HPLC);H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH acetate salt;glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine;L-Lysine,glycyl-L-arginylglycyl-L-a-aspartyl-L-seryl-L-prolyl-;(S)-6-Amino-2-((S)-1-((6S,12S,15S)-1-amino-6-(2-aminoacetamido)-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oyl)pyrrolidine-2-carboxamido)hexanoic acid;(S)-6-amino-2-((S)-1-((6S,12S,15S)-1-amino-6-(2-aminoacetamido)-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecane)pyrrolidine-2-carboxamido)hexanoic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.